...
首页> 外文期刊>Therapeutic advances in respiratory disease. >A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone Easyhaler? in routine clinical practice
【24h】

A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone Easyhaler? in routine clinical practice

机译:对哮喘或COPD患者的成年患者的非介入式转换研究萨尔梅勒/氟基塞松EasyHaler的临床疗效? 在常规临床实践中

获取原文
           

摘要

Background: Selection of the most appropriate device for a switch from one inhaler to an equivalent product is known to have a major impact on clinical outcomes in patients with asthma or chronic obstructive pulmonary disease (COPD). Salmeterol/fluticasone propionate (S/F) Easyhaler sup?/sup has been demonstrated to be therapeutically equivalent with a reference product. However, no data on real-life effectiveness are currently available for patients switching to S/F Easyhaler from another S/F inhaler. Methods: The aim of this prospective, open, multicenter, non-interventional study was to assess clinical effectiveness of propionate S/F Easyhaler in adult asthma and COPD patients switched from another inhaler. The primary endpoints were Asthma Control Test (ACT) and COPD Assessment Test (CAT). Secondary endpoints included assessments of patient satisfaction and preference and physician/nurse perception on S/F Easyhaler use. The study included three visits during a 12-week follow-up. Results: A total of 211 patients (160 with asthma; 51 with COPD) were included in the analyses. In patients with asthma, there was a statistically significant increase in the mean ACT score at week 12 (20.2?±?3.9) compared with the baseline (18.6?±?4.1), with a mean increase of 1.6 (±3.5) points ( p??0.0001). In patients with COPD, CAT score persisted from baseline (19.9?±?8.6) to week 12 (19.6?±?7.0). Patients were significantly more satisfied with Easyhaler and most patients preferred Easyhaler over their previous inhaler. The physicians/nurses reported that it was ‘very easy’ to teach the use of Easyhaler and the training took less than 5?minutes in most cases. Conclusion: The results from this prospective real-life clinical study indicate better or at least similar treatment control of asthma and COPD after switching to S/F Easyhaler from another S/F inhaler. This study also shows that S/F Easyhaler was favored by the patients and that it is easy to teach, learn and use in a real-life setting. The reviews of this paper are available via the supplemental material section.
机译:背景:已知从一个吸入器到同等产品的开关的最合适设备的选择对哮喘或慢性阻塞性肺病(COPD)患者的临床结果产生重大影响。 Salmeterol /氟替卡松丙酸盐(S / F)EasyHaler& sup&α& / sup&已被证明与参考产品相同。但是,目前没有关于从另一个S / F吸入器切换到S / F Easyhaler的患者的现实效果数据。方法:这一前瞻性,开放,多中心的非介入研究的目的是评估成年哮喘和从另一个吸入器切换的COPD患者中丙酸酯S / F Easyhaler的临床效果。主要终点是哮喘控制测试(ACT)和COPD评估试验(CAT)。辅助端点包括对S / F Easyhaler使用的患者满意度和偏好和医生/护士的评估。该研究包括在12周的随访期间三次访问。结果:分析中,共有211名患者(160例,带有COPD的哮喘; 51例)。在哮喘的患者中,与基线(18.6?±4.1)相比,第12周(20.2?±3.9)的平均动作得分统计上显着增加(20.2?±3.1),平均增加1.6(±3.5)点( P?&?0.0001)。在COPD的患者中,猫评分从基线持续存在(19.9?±8.6)至第12周(19.6?±7.0)。患者对EasyHaler和大多数患者在先前的吸入器上均优于Easyhaler。医生/护士报告说,教授Easyhaler的使用是“非常容易”,并且在大多数情况下,训练花费不到5分钟。结论:该前瞻性现实临床研究的结果表明,从另一个S / F吸入器切换到S / F Easyhaler后,对哮喘和COPD的哮喘和COPD的比例更好或至少。本研究还表明,S / F EasyHaler受到患者的青睐,并且易于教授,学习和使用在现实生活中。本文的审查可通过补充材料部分获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号